GLP-1 Analogs for Therapy of Multiple Sclerosis (MSGLP): Design, Methods and Rationale of Randomized, Controlled Clinical Trial

被引：0
|
作者：
Imrich, Richard [1 ]
Penesova, Adela [1 ]
Vlcek, Miroslav [1 ]
Radikova, Zofia [1 ]
Havranova, Andrea [1 ]
Siarnik, Pavol [2 ]
Sivakova, Monika [2 ]
Kollar, Branislav [2 ]
Turcani, Peter [2 ]
机构：
[1] Slovak Acad Sci, Biomed Res Ctr, Bratislava, Slovakia
[2] Comenius Univ, Dept Neurol 1, Fac Med, Bratislava, Slovakia
来源：
NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
14
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [31] Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis
    Ciccolo, Joseph T.
    Lo, Albert C.
    Jennings, Ernestine G.
    Motl, Robert W.
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (04) : 848 - 852
  • [32] GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial
    Wiberg, Sebastian
    Hassager, Christian
    Thomsen, Jakob Hartvig
    Frydland, Martin
    Hofsten, Dan Eik
    Engstrom, Thomas
    Kober, Lars
    Schmidt, Henrik
    Moller, Jacob Eifer
    Kjaergaard, Jesper
    TRIALS, 2016, 17
  • [33] GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial
    Sebastian Wiberg
    Christian Hassager
    Jakob Hartvig Thomsen
    Martin Frydland
    Dan Eik Høfsten
    Thomas Engstrøm
    Lars Køber
    Henrik Schmidt
    Jacob Eifer Møller
    Jesper Kjaergaard
    Trials, 17
  • [34] A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - rationale and design
    Glanzman, R.
    Curtin, F.
    Porchet, H.
    Schneble, H. -M.
    Vidal, V.
    Audoli-Inthavongb, M. -L.
    Lambert, E.
    Bernard, C.
    Hartung, H. -P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 852 - 852
  • [35] Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial
    Ronald Biemann
    Marina Penner
    Katrin Borucki
    Sabine Westphal
    Claus Luley
    Raik Rönicke
    Kathleen Biemann
    Cornelia Weikert
    Anke Lux
    Nikolai Goncharenko
    Hanns-Ulrich Marschall
    Jochen G. Schneider
    Berend Isermann
    Scientific Reports, 6
  • [36] A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design
    Curtin, Francois
    Porchet, Herve
    Glanzman, Robert
    Schneble, Hans Martin
    Vidal, Virginie
    Audoli-Inthavong, Marie-Laure
    Lambert, Estelle
    Hartung, Hans Peter
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 95 - 100
  • [37] Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial
    Biemann, Ronald
    Penner, Marina
    Borucki, Katrin
    Westphal, Sabine
    Luley, Claus
    Roenicke, Raik
    Biemann, Kathleen
    Weikert, Cornelia
    Lux, Anke
    Goncharenko, Nikolai
    Marschall, Hanns-Ulrich
    Schneider, Jochen G.
    Isermann, Berend
    SCIENTIFIC REPORTS, 2016, 6
  • [38] The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
    Sultan Linjawi
    Bruce W. Bode
    Louis B. Chaykin
    Jean-Pierre Courrèges
    Yehuda Handelsman
    Lucine M. Lehmann
    Abhishek Mishra
    Richard W. Simpson
    Diabetes Therapy, 2017, 8 : 101 - 114
  • [39] Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: Rationale and design
    Abraham, William T.
    Anand, Inder
    Aranda, Juan M., Jr.
    Boehmer, John
    Costanzo, Maria Rosa
    DeMarco, Teresa
    Holcomb, Richard
    Ivanhoe, Russell
    Kolber, Michael
    Rayburn, Barry
    AMERICAN HEART JOURNAL, 2012, 164 (05) : 638 - 645
  • [40] The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
    Linjawi, Sultan
    Bode, Bruce W.
    Chaykin, Louis B.
    Courreges, Jean-Pierre
    Handelsman, Yehuda
    Lehmann, Lucine M.
    Mishra, Abhishek
    Simpson, Richard W.
    DIABETES THERAPY, 2017, 8 (01) : 101 - 114
12345